Most cited papers from Cyteir Therapeutics (United States)
What are the most cited papers from Cyteir Therapeutics (United States)?
The most cited paper from Cyteir Therapeutics (United States) is "Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry" (John P. Guilinger et al., 2021), with 46 citations. Next come "Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes" (38) and "Enhancing the efficacy of glycolytic blockade in cancer cellsviaRAD51 inhibition" (27).
Showing 4 of 4 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry John P. Guilinger et al. · Bioorganic & Medicinal Chemistry | 19 May 2021 | 46 |
| 2 | Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes Jeremy J. Ratiu, Jeremy J. Racine, Muneer G. Hasham et al. · The Journal of Immunology | 2 May 2017 | 38 |
| 3 | Enhancing the efficacy of glycolytic blockade in cancer cellsviaRAD51 inhibition John J. Wilson, Kin-Hoe Chow, Nathan J. Labrie et al. · Cancer Biology & Therapy | 5 Sep 2018 | 27 |
| 4 | Identification of the mechanism of action of CYT-0851, an inhibitor of monocarboxylate transporter (MCT) mediated lactate transport B. Bradley, M.A. Belmonte, S. Kansara et al. · European Journal of Cancer | Oct 2022 | 3 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.